Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BiomX (NYSE: PHGE) logo — $PHGE

BiomX (NYSE: PHGE)

$PHGE

Founded 2015 Israel Israel 35 employees IPO Total: $169.30M Biotechnology, Health Care +2

General Information

Company Name BiomX (NYSE: PHGE)
Founded Year 2015
Location Israel Israel
Founders / Decision Makers
Team member
Employees 35
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage IPO
Business Model B2B, B2G, Platform
Revenue Model Product Sales, Project Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with BiomX (NYSE: PHGE). To contact BiomX (NYSE: PHGE), visit biomx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BiomX (NYSE: PHGE) compare?

A PDF of BiomX (NYSE: PHGE) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BiomX (NYSE: PHGE) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BiomX (NYSE: PHGE)

BiomX (NYSE: PHGE), founded in 2015 and headquartered in Israel, is an innovative player in the Biotechnology sector. The company operates within the broader fields of Health Care, Health and Wellness, and Pharmaceutical industries.

Specializing in microbiome-based technologies, BiomX is positioning itself as a significant contender in personalized health solutions. This advancement could play a pivotal role in areas such as chronic disease management and next-generation therapeutics.

The company's latest financial milestone was a Post Ipo Convertible investment, secured on 01 May 2026, demonstrating continued investor confidence. The investment was led by Mandragola, underscoring strong institutional backing. As the company advances its R&D capabilities, its pursuit of cutting-edge innovations promises to deliver compelling value propositions across the healthcare spectrum.

Business keywords: Microbiome Therapeutics, Microbiome Modulation, Phage Therapies, Drug Discovery, Preventive Medicine, Therapeutic Development, Scientific Research Collaboration, Innovation in Healthcare, Disease Prevention, Microbiome Imbalance, Microbiome Research

Services & Products

High-accuracy detection systems
AI-driven command and control systems
Drone-enabled technologies
Integrated security systems

Target Customers

Defense and Security Companies National Security Agencies Emergency Response Services Infrastructure Security Managers

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Convertible Undisclosed 1
Mandragola
01 May 2026
Post-IPO Debt $40.00M -
01 Jun 2025
Post-IPO Equity Undisclosed -
01 Feb 2025
Private Placement VC $50.00M 5
OrbiMed Cystic Fibrosis Foundation Nantahala Capital
OrbiMed, Cystic Fibrosis Foundation +3
01 Mar 2024
Private Placement VC $7.50M 2
OrbiMed Cystic Fibrosis Foundation
OrbiMed, Cystic Fibrosis Foundation
01 Feb 2023
Series B $50.00M -
01 Mar 2019
Support Program Undisclosed -
01 Nov 2018
Series A €21.80M 8
Johnson & Johnson Innovation Seventure Partners OrbiMed
Johnson & Johnson Innovation, Seventure Partners +6
01 May 2017
Spinout Undisclosed 1
Yeda
01 Dec 2015

BiomX (NYSE: PHGE) Alternatives & Competitors

View All Alternatives
BiomX (NYSE: PHGE) vs
Second Genome Inc.
Second Genome Inc. United States

Discovering and developing transformational precision therapies.

Series B
6 employees
Biotechnology, Health Care
Compare BiomX (NYSE: PHGE) vs Second Genome Inc.
BiomX (NYSE: PHGE) vs
AlphaBiomics
AlphaBiomics United Kingdom

The Precision Medicine Company

Seed
3 employees
Biotechnology, Health Care
Compare BiomX (NYSE: PHGE) vs AlphaBiomics
BiomX (NYSE: PHGE) vs
Yuanyin Bio
Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Also compare with: BiomX (NYSE: PHGE) vs EnteroBiotix EnteroBiotix View all alternatives

FAQ About BiomX (NYSE: PHGE)

$PHGE
BiomX (NYSE: PHGE) was founded in 2015.
BiomX (NYSE: PHGE) is headquartered in Israel.
BiomX (NYSE: PHGE) operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Microbiome Therapeutics, Microbiome Modulation, Phage Therapies and Drug Discovery. Its customers include Defense and Security Companies, National Security Agencies and Emergency Response Services.
BiomX (NYSE: PHGE) has a B2B, B2G and Platform business model. Its revenue comes from Product Sales, Project Based and Licensing.
BiomX (NYSE: PHGE) has approximately 35 employees.
BiomX (NYSE: PHGE) has completed 9 funding rounds, raising a total of $169.30M. The latest funding stage is IPO.
BiomX (NYSE: PHGE) offers: High-accuracy detection systems, AI-driven command and control systems, Drone-enabled technologies, Integrated security systems.
Top alternatives and competitors to BiomX (NYSE: PHGE) include Second Genome Inc., AlphaBiomics, Yuanyin Bio, Avenzo Therapeutics, DELIVER Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BiomX (NYSE: PHGE) and Second Genome Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BiomX (NYSE: PHGE), https://bouncewatch.com/company/biomx-inc, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes